Related Articles
Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti‑cancer agents in the adjuvant setting
Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX‑4 chemotherapy
Prediction of high-risk patients by genome-wide copy number alterations from remaining cancer after neoadjuvant chemotherapy and surgery
A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection Corrigendum in /10.3892/mco.2019.1879
A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients